Ouk, Michael
Wu, Che-Yuan
Rabin, Jennifer S.
Jackson, Aaron
Edwards, Jodi D.
Ramirez, Joel
Masellis, Mario
Swartz, Richard H.
Herrmann, Nathan
Lanctôt, Krista L.
Black, Sandra E.
Swardfager, Walter http://orcid.org/0000-0002-0030-8908
Funding for this research was provided by:
Alzheimer's Drug Discovery Foundation (20141208)
Weston Brain Institute (20121211)
Alzheimer's Association (AARG501466)
Brain Canada (AARG501466)
Canadian Institutes of Health Research (PJT-159711)
Michael J. Fox Foundation for Parkinson's Research
Alzheimer's Research UK
Heart and Stroke Foundation Canadian Partnership for Stroke Recovery
LC Campbell Cognitive Neurology Unit
Sunnybrook Health Sciences Centre Department of Psychiatry
Article History
Received: 6 October 2020
Accepted: 25 January 2021
First Online: 11 February 2021
Ethics approval and consent to participate
: As determined by the University of Washington Human Subjects Division, the NACC database itself is exempt from IRB review and approval because it does not involve human participants, as defined by federal and state regulations. However, all contributing ADCs are required to obtain informed consent from their participants and maintain their own separate IRB review and approval from their institution prior to submitting data to NACC.
: Not applicable.
: MO, CW, JSR, AJ, JDE, JR, MM, RHS, NH, KLL, SEB, and WS report no potential competing interests.